Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.7 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.064 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.074 | 0.8 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |